Insiders · PACB

David Botstein

Director at Pacific Biosciences Of California, Inc. (PACB)

David Botstein has filed 4 insider reports with the SEC since February 2021, as director at Pacific Biosciences Of California, Inc. (PACB). David Botstein made no open-market purchases or sales in the last 12 months. The latest filing, on May 26, 2023, reports grant or award at Pacific Biosciences Of California, Inc. (PACB).

Filings
4
Companies
1
Bought on market
None
Sold on market
$7.94M

Companies where David Botstein is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Pacific Biosciences Of California, Inc. logo
PACB
Pacific Biosciences Of California, Inc.
Director0$7.94M$1.83May 26, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare David Botstein with

Other insiders at the same companies

Questions about David Botstein

What is David Botstein's role at Pacific Biosciences Of California, Inc.?
David Botstein reports to the SEC as director at Pacific Biosciences Of California, Inc. (PACB), according to the latest filing on May 26, 2023.
Has David Botstein bought or sold stock recently?
The most recent open-market sale was on February 12, 2021: sold 160,000 shares of Pacific Biosciences Of California, Inc. (PACB) for $7.94M at an average of $49.62.
How do I get alerts when David Botstein files?
Follow David Botstein on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David Botstein (SEC CIK 0001554630). Totals count each trade once, skipping amendments whose original is on file, from Feb 18, 2021 on. View on SEC EDGAR